Both transmembrane and extracellular cues, one of which is collagen XIII, regulate the formation and function of the neuromuscular synapse, and their absence results in myasthenia. We show that the phenotypical changes in collagen XIII knock-out mice are milder than symptoms in human patients, but the Col13a1 -/-mice recapitulate major muscle findings of congenital myasthenic syndrome type 19 and serve as a disease model. In the lack of collagen XIII neuromuscular synapses do not reach full size, alignment, complexity and function resulting in reduced muscle strength. Collagen XIII is particularly important for the preterminal integrity, and when absent, destabilization of the motor nerves results in muscle regeneration and in atrophy especially in the case of slow muscle fibers. Collagen XIII was found to affect synaptic integrity through binding the ColQ tail of acetylcholine esterase. Although collagen XIII is a muscle-bound transmembrane molecule, it also undergoes ectodomain shedding to become a synaptic basal lamina component. We investigated the two forms' roles by novel Col13a1 tm/tm mice in which ectodomain shedding is impaired. While postsynaptic maturation, terminal branching and neurotransmission was exaggerated in the Col13a1 tm/tm mice, the transmembrane form's presence sufficed to prevent defects in transsynaptic adhesion, Schwann cell invagination/retraction, vesicle accumulation and acetylcholine receptor clustering and acetylcholinesterase dispersion seen in the Col13a1 -/-mice, pointing to the transmembrane form as the major conductor 
Introduction
A number of nerve-and muscle-derived proteins contribute to the structure, functionality and plasticity of the neuromuscular junction (NMJ) and enable cross-talk between the motor neuron and muscle fiber. Loss or compromise of molecular interactions at the NMJ often leads to congenital myasthenic syndrome (CMS), with a heterogeneous disease etiology and an outcome varying from mild muscle weakness to lethality (1, 2) . Collagen XIII is recognized as a component of NMJs (3) , and on account of it occurring as a transmembrane and shed protein (4, 5) it could be considered both as a synaptic basement membrane (BM) component and a postsynaptic adhesion molecule. Recently, mutations in COL13A1 were identified in patients with CMS, and this novel subtype of CMS was designated as type 19 (CMS19, OMIM #616720) (6) .
The majority of CMSs are of postsynaptic origin, often arising from mutations in the acetylcoline receptor (AChR) subunit genes, but also in genes encoding proteins that form complexes with AChRs and affect AChR clustering, such as Rapsyn, Dok-7 (downstream of tyrosine kinase 7) and MuSK (muscle-specific receptor tyrosine kinase). Presynaptic forms of CMS are rare and primarily caused by mutations in CHAT, the gene encoding choline acetyltransferase (1, 2) . Three types of synaptic CMS exist in which COLQ (coding for the collagenous tail of acetylcholine esterase, AChE), laminin b2 and agrin, all critical components of the synaptic basal lamina, are mutated. Deficiency of ColQ results in NMJs lacking AChE (7) (8) (9) . ColQ is bound to the synaptic BM by perlecan (10) and MuSK (11) where it contributes to AChR clustering through MuSK interaction (12, 13) . Laminin b2 is required for clustering of presynaptic Ca 2þ channels (14) and thus is essential in postnatal presynaptic differentiation (15) while agrin is indispensable for motor synapse maintenance (16, 17) . Furthermore, the synaptic BM components collagen IV and nidogen-2 orchestrate both pre-and postsynaptic maturation and stabilization (18, 19) . Here, we asked whether deletion of collagen XIII in mice results in CMS19-like muscle phenotypes and sought to understand the mechanisms of collagen XIII action at the NMJ. Our results indicate that collagen XIII is essential in the correct assembly of various NMJ components postnatally, such as ColQ-tailed AChE and synaptic vesicles. Our results reveal dysfunction and destabilization of motor nerves as a causative etiology in the lack of functional collagen XIII. Furthermore, sarcolemmal-anchored collagen XIII contributes to transsynaptic adhesion thereby enhancing synaptic organization, complexity and function.
Results
Phenotypes in collagen XIII knock-out mice resemble human muscle pathologies in CMS19 CMS19 patients, characterized by mutations in COL13A1, suffer from muscle weakness exemplified by breathing and feeding problems starting soon after birth (6) . Related to respiratory insufficiency in CMS19 patients we observed fast and superficial breathing in the collagen XIII knock-out mice. Previously, we have shown that collagen XIII knock-out mice are myasthenic and although their NMJs are normal in size at birth, a delay in NMJ development is obvious at two weeks of age and onwards (3) . In addition to muscle weakness, the disease affects growth and development of human patients seen as dysmorphic facial features and skeletal abnormalities (6) , but here we focused on further characterizing the muscle pathologies in the collagen XIII knock-out mice. We found that mice lacking collagen XIII had significantly reduced body weight at puberty and when aging, while not in adulthood (Fig. 1A, P28 females P ¼ 0.0005 and males P ¼ 0.0198, P56 females P¼ 0.0136, P469 females P ¼ 0.0270 and males P¼ 0.0485). To better understand the effects of collagen XIII in relation to muscle pathology, we assessed two different types of muscles in the Col13a1 -/-mice; the respiratory muscle diaphragm and the slow-twitch limb muscle soleus. Macroscopically the diaphragm was pressed deeper towards the thoracic cavity in Col13a1 -/-than in wild-type mice and the soleus muscle was smaller in size at P84. Muscle weight differed from wild-type mice only in the soleus, where it was decreased at P84 although it was comparable to wild-type at the onset of NMJ maturity at P28, suggesting a progressive loss of muscle mass ( Fig. 1B and C, C: P28 P ¼ 0.0613 and P84 P ¼ 0.0007). Consistently, whole muscle MRI of one CMS19 patient at the age of 2 years was normal suggesting normal muscle bulk, while that of two other patients was claimed reduced at the age of 5 years on clinical examination (6) . Histological analysis of the Col13a1 -/-mice revealed an increased proportion of small muscle fibers and a slight, but yet significantly elevated number of centrally located nuclei both in the diaphragm and soleus (( Fig. 1D -F, I-K) F: <0.5 mm 2 P ¼ 0.0326 and >1 mm 2 P ¼ 0.0317, J:
P ¼ 0.0428, K: <1.0 mm 2 P¼ 0.0232 and 1-1.5 mm 2 P ¼ 0.0444), indicating muscle regeneration, and in view of the reduced muscle to body weight ratio, atrophy of the soleus muscle due to the lack of collagen XIII. Furthermore, especially in the soleus small muscle fibers were scattered and angular in shape (Fig. 1I) . Similarly, muscle biopsy from a young patient suffering from CMS19 showed abnormal fiber size variation and some, but not extensive central nuclei deposition (6) . To further analyze the diaphragm and soleus muscles we stained cryosections for fast and slow muscle fiber markers. These markers appeared normal in Col13a1 -/-diaphragms ( Fig. 1G and H) , whereas there was a shift in the muscle fiber type distribution towards fast/mixed at the expense of slow muscle fibers in the soleus ( Fig. 1L and M) . Atrophy of slow muscle fibers in the Col13a1 -/-soleus appears progressive since the fast/slow muscle fiber distribution was normal in this muscle at P28 (Supplementary Material, Fig. S1 ). In the lack of collagen XIII selected muscles are thus not capable of responding with appropriate regeneration but end up with a decrease in the fibertype diversity and count, and therefore permanently compromised muscle quality. A significant upregulation of fetal myosin expression was also reported for the human patients (6), indicating muscle regeneration (20) . We tested whether the embryonic and neonatal myosin expression, coded by myosin heavy chain 3 (Myh3) and Myh8 genes, respectively, and known to be re-expressed during muscle regeneration (20) , was altered due to a lack of collagen XIII. Indeed, real time quantitative PCR (RT-qPCR) revealed significant increases in the transcript levels of both Myh3 and Myh8 in the Col13a1 -/-soleus when compared to wild-type ( Fig. 1N -O, N: P ¼ 0.0159 and O: P ¼ 0.0159) suggesting similar and Col13a1 -/-mice (-/-), respectively. (B, C) Muscle weight of the diaphragm (DIA) and soleus (SOL) normalized by body weight (bw) at P28 and P84; the muscle weight/ body weight ratio of wild-type mice is defined as 100%. P28;P84, wild-type N ¼ 9;4, Col13a1 
, n¼ fiber number. (F, K) Diaphragm (F) and soleus (K) fiber size. N ¼ 5 in both, wild-type upregulation of fetal myosins in the Col13a1 -/-mice than in human patients. Two CMS19 patients were unsuccessfully treated with anticholinesterase medication as primary treatment (6) . However, a combination of salbutamol and 3,4-diaminopyridine (DAP), the latter primarily acting at the presynaptic site (21) , was successfully used to treat one patient (6) . Here we used the Col13a1 -/-mice to test whether blocking repolarization with a potassium channel blocker and exposing the collagen XIII deficient postsynaptic membrane to an extended and enlarged stimulus would restore muscle function. Indeed, the muscle strength was improved since the grid hanging time of all five tested Col13a1 -/-male mice was significantly extended post DAP injection ( Fig. 1P and Q, P ¼ 0.0425) without any immediate, visible adverse effects. Prior to DAP injection all the wild-type controls could hang for at least 5 minutes (data not shown), set as maximum, while latency to fall for Col13a1 -/-mice was around oneminute suggesting muscle weakness in the lack of collagen XIII ( Fig. 1P and Q) . Taken together, although the collagen XIII deficient mice are more resistant to genetic loss of collagen XIII protein and appear to have less severe symptoms than the human patients, the mutant mice are remarkably similar to the CMS19 patients in terms of muscle findings.
Collagen XIII is not shed in a novel Col13a1 tm/tm mouse model and transmembrane form alone is present
Our previous data indicate that shed collagen XIII is capable of inducing postsynaptic maturation in vitro (3). To further elucidate the roles of both transmembrane and shed collagen XIII, we designed a mouse model in which the furin-type pro-protease convertase recognition sequence required for shedding (22) was mutated. This resulted in all protein being of the transmembrane form in a novel Col13a1 tm/tm mouse model ( Fig. 2A and B). Collagen XIII mRNA expression in P84 muscles of the ensuing Col13a1 tm/tm mice were slightly, but not significantly decreased varying from 73% to 93%, when compared to wild-type mice ( Fig. 2E and F) . Western blots of Col13a1 tm/tm tissues revealed one or two high-mobility band(s) representing the transmembrane form(s) of collagen XIII, whereas the shed form, detected in wild-type as a lower molecular weight band(s), was absent in all Col13a1 tm/tm tissues studied (Fig. 2C , G, H).
Moreover, primary fibroblasts extracted from Col13a1 tm/tm embryos were capable of producing collagen XIII protein, as detected in cell lysates, but incapable of secreting a shed ectodomain in to the culture medium (Fig. 2D ). Western blots revealed that the relative amounts of total collagen XIII protein in comparison to the housekeeping protein Gapdh were 133% and 16% in the Col13a1 tm/tm diaphragm and soleus muscles, respectively, compared with wild-type muscles ( Fig. 2I and J) . In the wild-type muscles the proportion of the transmembrane form was about 20% of the total collagen XIII amount ( Fig. 2I and J) . In the Col13a1 tm/tm soleus the transmembrane form occurred at roughly normal levels ( Fig. 2J) , although the total collagen XIII protein level was reduced, while in the diaphragm, with a slightly increased total collagen XIII level, there was a 5.6-fold increase in the amount of the transmembrane form compared with wild-type (Fig. 2I) . The ensuing mutant mice were macroscopically normal and fertile, and had a normal life-span accompanied by a significant decrease in the body weight at aging (Supplementary Material, Fig. S2A Fig. S3A -C) whereas the shed collagen XIII ectodomain may predominate at the myotendinous junction, another location for collagen XIII in the muscle (3, 23, 24) . In fact, the Col13a1 tm/tm NMJs were characterized by notably sharper collagen XIII staining than controls with particularly pronounced AChR cluster borders in both muscles studied ( Fig. 2K and L) . Thus, the transmembrane collagen XIII-derived staining pattern in the Col13a1 tm/tm junctions is indicative of the differences between these and wild-type muscles and suggests an existence of the transmembrane collagen XIII in unique domains of the NMJ borders.
Although both body and muscle weight of the diaphragm and soleus at P28 and P84 were unaltered in the Col13a1 Collagen XIII is essential for postsynaptic maturation and forced expression of transmembrane collagen XIII drives enlargement and fragmentation of AChR clusters Defects in AChR clustering have been observed in cultured mouse myoblasts carrying mutated Col13a1 (6) and in Col13a1 -/-mice (3). To assess the influence of having only the transmembrane collagen XIII on postsynaptic organization, we assessed postnatal maturation of the NMJ in wild-type and mutant mice (Fig. 3A) . As previously documented, AChR clusters remained small and immature in mice lacking collagen XIII ( Fig. 3A and B). When we assessed the size of the AChR-positive area at the NMJ, the cluster size was decreased in the Col13a1 -/-mice by 33% and 41% at P28 and P84, respectively, compared with agematched controls (Fig. 3C , P28: P ¼ 0.0286 and P84: 0.0058). The difference in the AChR clusters between controls and the Col13a1 -/-mice at two-week-of-age and onwards is consistent with the congenital nature of the human myasthenic syndrome (6) . When ectodomain shedding is prohibited and all collagen XIII is transmembrane in the Col13a1 tm/tm mice ( Fig. 2G and I ), the AChR clusters were also abnormal -from P56 onwards they progressively became large and highly fragmented ( mice, while at P84 it was increased by 37% (Fig. 3C ). Fragmentation increased hand in hand with the size (Fig. 3D) . Thus, aberrant expression of the transmembrane collagen XIII and lack of shedding drives enlargement of the motor junctions compared with the Col13a1 -/-mice and even controls, and at the same time making them vulnerable to fragmentation. The AChR cluster changes in the Col13a1 -/-and Col13a1 tm/tm mice persisted in all further time points although fragmentation was also seen in wild-types from P182 onwards, but to a lesser extent (Fig. 3A) .
Collagen XIII locates at the functional unit of the NMJ, binds ColQ and contributes to the distribution pattern of AChE at the NMJ In order to evaluate the means by which collagen XIII affect the motor synapse size and AChR clustering we next studied the collagen XIII fine-localization with other NMJ and muscle markers. Whole mount collagen XIII staining revealed a spotlike distribution of collagen XIII throughout the a-BTX-labeled (a-bungarotoxin) regions of the motor endplate ( Fig. 2K and L). NMJs on both fast and slow muscle fibers contained collagen XIII (data not shown) whereas Col13a1 -/-junctions were devoid of staining ( Fig. 2K and L). The strongest collagen XIII signal was detected in the soleus where the staining prominently accumulated inside the AChR cluster borders (Fig. 2L) . Compared with other NMJ markers we found that the collagen XIII pattern was not as evenly distributed as the synaptic AChE pattern (labelled with Fasciculin II), which closely followed the AChR pattern and extended slightly beyond the borders of the collagen XIII staining (Supplementary Material, Fig. S3A ). In contrast, collagen XIII pattern appeared slightly broader than that for the synaptic vesicle protein Syt-2 (synaptotagmin 2; Supplementary Material, Fig. S3B ), and it was adjacent rather than overlapping with the localization of the active zone (AZ) protein Bassoon Fig. S3C ). This accumulation of collagen XIII at sites with other synaptic proteins marks it as a component of the functional NMJ unit. Since postsynaptic receptor clusters were affected in both collagen XIII modified mouse lines (Fig. 3) we evaluated the molecular architecture of the NMJ further for both postsynaptic and synaptic cleft markers. There was no difference in the postsynaptic dystrophin distribution suggesting that the dystrophin glycoprotein complex was normally composed in the collagen XIII mutants (Supplementary Material, Fig. S4 ). However, the pattern of synaptic AChE, indicated by both fluorescently labelled Fasciculin II (data not shown) and anti-AChE antibody staining, was diffuse and dispersed beyond postsynaptic receptor cluster borders in the absence of collagen XIII while it nicely followed the receptor cluster borders in wild-type and Col13a1 tm/tm mice ( Fig. 4A and B) thus suggesting a role for collagen XIII in supporting a correct AChE distribution at the NMJ. To test whether collagen XIII directly interacts with AChE, the amount of AChE bound on a solid collagen XIII surface was measured (25) . Purified ColQ-tail-associated AChE from Torpedo californica and Electrophorus electricus showed significant affinity to the collagen XIII protein while ColQ-lacking dimeric or tetrameric AChE did not (Fig. 4C) . This interaction between collagen XIII and asymmetric AChE, however, had no effect on the enzyme activity and the binding was diminished by increasing the salt concentration indicating noncovalent interaction between the two proteins (data not shown). Binding of asymmetric AChE to collagen XIII was specific since it did not bind to collagen I or BSA (Fig. 4D) . We further tested the binding of asymmetric AChE with collagen XIII fragments and found that the ColQ-tailed AChE bound to the COL3 domain which is the largest and outermost of the collagenous domains in collagen XIII (Fig. 4E) .
We next assessed whether the localization of ColQ was altered in the collagen XIII mutants. Similarly to the AChE pattern, ColQ did not perfectly align with the AChRs in the Col13a1 -/-mice but dispersed to the surroundings ( Fig. 4F and G) , whereas it appeared normally distributed in the Col13a1 tm/tm mice. Thus, transmembrane collagen XIII may participate in defining the AChE distribution pattern at the neuromuscular synapse via binding its ColQ tail (Fig. 4A, B , F, G).
Transmembrane collagen XIII contributes to transsynaptic adhesion and by doing so promotes presynaptic differentiation and function
Interaction missing between collagen XIII and ColQ may explain postsynaptic defects seen in collagen XIII deficiency since ColQ/ MuSK signalling has been shown to contribute to AChR clustering (12, 13) . Next, we addressed how collagen XIII mediates its effects on the nerve terminus. As already previously shown for P56 in the Col13a1 -/-mice (3), the acetylcholine-containing vesicles (AChVs) did not exclusively accumulate at the nerve terminus even at P84, but were also found in the pre-terminal axon in the knock-out mice while AChVs were fully aligned with postsynaptic receptor clusters in the Col13a1 the Col13a1 tm/tm mice compared to controls, whereas Syt-2 levels appeared reduced at Col13a1 -/-synapses (Supplementary Material, Fig. S5A ). Similar results were obtained for another vesicle-associated protein, vesicular acetylcholine transporter, suggesting that these differences reflect differences in AChV clustering rather than an expression of single vesicle associated proteins (Supplementary Material, Fig. S5B ).
In order to better characterize the role of transmembrane collagen XIII on the presynaptic site ultrastructural analysis was performed. In the diaphragm the adhesion between preand postsynaptic structures in the Col13a1 tm/tm NMJs was comparable to wild-type and no Schwann cell invagination could be seen in contrast to the defects already previously reported for the knock-out mice (3) (Fig. 5A ). This indicates that the transmembrane collagen XIII is both sufficient and necessary in conveying transsynaptic adhesion ( Fig. 5A and B) . In the wild-type diaphragm AChVs were clustered near AZs while in the Col13a1 tm/tm presynaptic termini the vesicles were densely packed ( Fig. 5A ) and were 2.7-fold more numerous than in controls ( Fig. 5C , P ¼ 0.0022). AZ numbers were also significantly elevated in Col13a1 tm/tm NMJs, suggesting enhanced exocytosis (Fig. 5A , B, D, P ¼ 0.0071), whereas total loss of collagen XIII led C;E;G.*P < 0.05, **P < 0.01, ***P < 0.001.
to a decreased AZ number (3). In line with this, Bassoon immunoreactivity, a molecular marker of AZs, was reduced in the Col13a1 -/-mice (Supplementary Material, Fig. S3C ). Additionally, we detected increased endocytosis in the Col13a1 tm/tm termini in the diaphragm (Fig. 5A , B, E, P ¼ 0.0037). Induction of exocytosis in the presence of a lipophilic dye FM 1-43FX confirmed that endocytosis was efficient at NMJs of Col13a1 tm/tm diaphragms, while it was patchy and not fully covering the receptor cluster area in the Col13a1 -/-mice, which also showed compromised adhesion and alignment, and reduced vesicle cycling (Supplementary Material, Fig. S5C ). The transmembrane collagen XIII alone is therefore capable of rescuing many phenotypical changes associated with collagen XIII loss. Due to alterations in the AChV distribution, number and cycling in the Col13a1 tm/tm mice, we quantified NMJ function in the presence of transmembrane collagen XIII alone and compared the data with similar experiments previously performed in the Col13a1 -/-mice (3). The resting membrane potential of muscle fibers was unaltered in the Col13a1 tm/tm mice when compared to controls (data not shown). Next we analyzed the characteristics of the postsynaptic membrane and spontaneous activity of the nerve termini by measuring MEPPs. We detected no difference in the amplitude of MEPPs at Col13a1 tm/tm NMJs, but the MEPP frequency was significantly increased indicating increased spontaneous presynaptic activity ( Fig. 5F and G, P ¼ 0.0002). This is in contrast to the Col13a1 -/-NMJs in which MEPP amplitude and frequency were both significantly decreased (3). As previously shown, both Ca 2þ -independent and -dependent evoked release of the readily releasable pool (RRP) of AChVs was dramatically reduced in the lack of collagen XIII (3) resulting from a decrease in the number of docked vesicles. Here, when the Ca 2þ -independent release of the RRP was induced by hypertonic sucrose solution, a significant increase in the frequency of evoked MEPPs over wild-type was detected in the Col13a1 tm/tm NMJs ( stimulation when compared to wild-type mice indicating that all vesicle pools were enlarged (Fig. 5L) . Again, these results are contrary to the findings in the absence of all collagen XIII (3). These data suggest a role for transmembrane collagen XIII in transsynaptic adhesion which supports the accumulation of presynaptic components such as neurotransmitter vesicles and AZs thereby enhancing presynaptic functional capacity.
Collagen XIII regulates presynaptic organization in a retrograde manner
Due to detected changes in presynaptic components we next studied presynaptic organization in the collagen XIII modified mice. We found striking differences in the organization of axon termini in mice that lacked all forms of collagen XIII, versus those that lacked only the shed form and expressed just transmembrane form. Firstly, increased terminal branching of the motor axons was observed in the Col13a1 tm/tm NMJs while in the knockout mice the terminal complexity was greatly decreased indicated by significantly decreased level of terminal divisions as well as number of terminal branches and tips (Fig. 6A-F 
Col13a1
-/-P ¼ 0.0002). Secondly, in the absence of total collagen XIII, neurofilament-containing elements were thin and nerve termini failed to fully cover AChR-rich clusters ( Fig. 6A and B) . Furthermore, in both collagen XIII modified mouse lines swelling of the preterminal axons indicative of autophagosomes in dystrophic axons was observed (26) (Fig. 6A) . In addition to the defective alignment of pre-and postsynaptic partners, retraction of terminal Schwann cells was observed in mice lacking collagen XIII, and both of these findings were combined with a dispersion of AChR clusters (Fig. 6A, B, G, H) . Thus, transsynaptic adhesion mediated by collagen XIII significantly supports nerve terminal structural integrity, differentiation and activity, and when lacking, leads to deleterious effects on the muscle functional capacity as shown both for collagen XIII deficient man and mouse.
Discussion
Collagen XIII was recently identified as a postsynaptic NMJ protein required for NMJ maturation (3). The lack of collagen XIII at NMJs in mice manifests as muscle weakness and atrophy, and the functional and morphological findings in the muscles of the knock-out mice were highly similar to those in CMS19 patients with loss-of-function mutations in COL13A1 (6). Here we identified an interaction of collagen XIII and the collagenous stalk ColQ of the enzyme AChE needed for breakdown of synaptic neurotransmitters at the NMJ, which could in part explain the postsynaptic and synaptic effects of collagen XIII. Collagen XIII exists both as a transmembrane collagen and a soluble BM component on account of ectodomain shedding. We compared a novel Col13a1 tm/tm mouse line, in which shedding of collagen XIII is inhibited by mutation of a furin-type pro-protease recognition sequence, with total collagen XIII knock-out mice, and found the transmembrane form of collagen XIII to be able to restore many defects seen in the lack of both collagen XIII forms (Table 1) . However, forced expression of transmembrane collagen XIII produced a NMJ phenotype differing from wild-type and Col13a1 -/-NMJs. Studies on mice suggest that transmembrane collagen XIII significantly contributes to transsynaptic adhesion and by doing so enhances presynaptic structure and function. In the lack of collagen XIII such support is missing leading to destabilization of NMJs, motor nerve dysfunction and muscle atrophy.
Synaptic collagen XIII-ColQ interaction is essential for correct AChE assembly and the transmembrane form supports NMJ maturation
Without both forms of collagen XIII AChR cluster development and maturation is delayed and AChR clusters remain small and simple (3), and further examination revealed AChR dispersion and diffusion by time. In the Col13a1 -/-mice AChR dispersion was also accompanied with AChE diffusion and in protein binding studies the ColQ-tailed AChE and collagen XIII were found to interact. Furthermore, the in vivo significance of this was evidenced by dislocation of ColQ at the NMJs of Col13a1 -/-mice.
Forced expression of the transmembrane collagen XIII did not compromise AChE or ColQ localization at the synapses suggesting a major role for the transmembrane form in keeping these NMJ components at their correct places. Interestingly, ColQ is known to regulate AChR density, cluster size and postsynaptic differentiation and plasticity through MuSK interaction (12, 13) , and the BM component perlecan is critical for anchorage of AChE at NMJs (10) . On the other hand, also collagen XIII is known to interact with perlecan (27) . While perlecan appears critical for bridging AChE at NMJs, we propose that collagen XIII is needed for fine localization of ColQ-tailed AChE at the NMJ. Shed ectodomain of collagen XIII was found enhancing NMJ maturation in an autocrine manner (3) but here we suggest that transmembrane collagen XIII is capable of doing that too, even more so. This is supported by a finding that in mice expressing solely transmembrane collagen XIIII AChR clusters developed normal until maturity whereafter cluster size exceeded wildtype controls. Reported interactions between collagen XIII and synaptic BM components nidogen-2 and collagen IV (27) suggest additional binding partners and signaling routes by which collagen XIII may contribute to NMJ maturation and stabilization.
Distinct forms of collagen XIII contribute to unique aspects of presynaptic development
Besides postsynaptic and synaptic effects we found presynaptic changes in the Col13a1 tm/tm and Col13a1 -/-mice that suggest a role for collagen XIII in motoneuron stability in maturing NMJs, whereas its homolog CLAC-P/collagen XXV is critical in NMJ development (28) . In the loss of both collagen XIII forms neurofilament staining revealed a fragile organization of the presynaptic skeleton and decreased terminal branching, occasionally accompanied by neurofilament aggregation and retraction of both terminal axons and Schwann cells. In contrast, the presence of only the transmembrane form led to a prominent preterminal cytoskeleton and increased terminal branching, and ultrastructurally normal synaptic adhesion of muscle and nerve. Investigations on another collagen, type XVIII and its proteolytic fragment, have shown it to organize certain central nervous system termini, likely by binding and signaling through integrin a1b1 (29) . In the case of collagen XIII, we consider a3b1 integrin as a potential preterminal receptor on account of the observed interaction between these two molecules (30) and the observed localization of the a1 integrin subunit in preterminal structures (31) . Total loss of collagen XIII also decreased AChV accumulation and AChV cycling, whereas the transmembrane form was sufficient to accelerate accumulation, spontaneous and Ca 2þ -dependent and -independent release, and cycling of AChVs in Col13a1 tm/tm mice. Thus, the transmembrane collagen XIII acts as a presynaptic stabilizer expediting preterminal branching and differentiation. However, since NMJs in Col13a1 tm/tm mice exceeded the complexity of wild-type synapses, shedding of transmembrane form is required for collagen XIII as well as NMJ homeostasis and aberrant expression of transmembrane collagen XIII results in synaptic activity exceeding that of controls which may explain fragmentation of AChR clusters, muscle regeneration and axonal aberrations. Moreover, the deteriorated presynaptic cytoskeleton may have an impact on synaptic homeostasis by impairing anterograde and/or retrograde axonal trafficking, known to lead to axonal degeneration, motoneuron retraction and cell death (32) . This could by itself result in the compromised transport of synaptic vesicles and axonal pruning seen in the Col13a1 -/-mice.
From molecules and cells to organisms -collagen XIII at NMJs of mice and men
Out of 15 CMS patients without known etiology 3 harbored two different mutations in the COL13A1 gene, both predicted to lead to loss of the protein (6). Although Logan et al. showed normal localization of the NMJ components at the infancy we here detected misplacement of presynaptic, synaptic and postsynaptic components in adult mice lacking collagen XIII. However, the clinical and histopathological muscle features of these CMS19 patients and the collagen XIII deficient mice are remarkably similar. Firstly, both human mutations are expected to lead to loss of the collagen XIII protein, or at least its function, and the NMJs were shown by immunoreactivity to lack collagen XIII similar to the knock-out mice. Secondly, loss of collagen XIII led to compromised neuromuscular transmission and muscle weakness both in man and mouse. Thirdly, both human and mouse loss-of function mutations resulted in defective AChR clustering. Fourthly, the muscles in mouse and man had fiber size variability and a modestly increased number of central nuclei indicative of muscle regeneration which was not adequate in all muscles but resulted in atrophy and permanently altered muscle tissue. Fifthly, the increased expression of fetal muscle proteins in patients, likely reflecting delayed muscle development or exposition to muscle regeneration, is in line with our finding of an elevation in fetal-type myosin heavy chains, and at least in the mouse model especially slow muscle fibers were dependent on NMJ stabilization via transsynaptic adhesion mediated by transmembrane collagen XIII. Even if shown here just in short term experiment, DAP enhanced the muscle function both in mice and men. However, it needs to be kept in mind that DAP served as a medication in the single patient treated only in combination with salbutamol (6).
In conclusion, we suggest that collagen XIII regulates NMJ integrity through multiple interactions and many of such effects are mediated by the transmembrane form while its proteolytic shedding has a role in the NMJ homeostasis. Although phenotypes in collagen XIII knock-out mice resemble muscle pathologies in CMS19 patient, further analyses of the mouse models is required to reveal pathologies in different organs such as the lung, known to harbor the highest collagen XIII expression in an array of tissues (3, 33) , as well as in bone, where overexpression of collagen XIII leads to bone overgrowth (33) . Such future investigations may lead to even better understanding of CMS19.
Materials and Methods

Generation and maintenance of mice
The Col13a1 tm/tm mouse line was generated by targeting with a vector containing a selection cassette flanked by LoxP sites in the first intron and an -RRRR-to -ATAA-mutation in exon two to delete a furin type proprotein convertase recognition sequence. Mice were cross-bred with C57BL/6 mice and the selection cassette was removed by breeding with Tg (CAG-cre) 13Miya mice (34) . Permission to maintain mice was admitted by the Finnish Animal Care and Use Committee. All the mouse experiments followed the European Community Council Directive (September 22, 2010; 2010/63/EEC), national legislation and the regulations for the care and use of laboratory animals. Mice were maintained in a specific pathogen-free facility in the University of Oulu. Mice of both sexes were used in the experiments and wild-type littermates were used as controls.
Tissue transcript and protein level analyses
Total RNA and whole tissue proteins as well as proteins from E13.5 mouse embryonal fibroblast cultures were extracted using Tri Reagent system (Sigma-Aldrich). Extracted proteins and precipitated culture media were run in 8% reduced SDS-PAGE gels and blotted with primary and secondary antibodies. Total RNA was used for reverse transcription with iScript tm cDNA Synthesis Kit (Bio-Rad) and quantitative real-time PCR using iTaq tm Universal SYBRV R Green Supermix kit (Bio-Rad) according to manufacture rs protocol. Detailed information on primers can be found in the Supplementary Material, Table S1 .
Cell culture
To establish mouse embryonic fibroblasts E13.5 embryos from heterozygous matings were dissected out, and the head and hematopoietic organs were removed. The trunk was cut into small pieces and incubated in 0.25% trypsin/PBS containing 100 mg/ml DNAse for 15 min at þ37 C in 1 ml volume. The cells were plated on 10 cm dishes with 10% FBS, 1% non-essential amino acids, 1% penicillin and 1% streptomycin/DMEM, and medium and cells were collected at passage two. The cells were lysed with PBS-0.1% Triton X-100 and proteins in the medium were precipitated with an equal volume of methanol at À20 C. Proteins were run in 8% reduced SDS-PAGE gels and blotted with a rabbit anti-mouse collagen XIII antibody (ColXIII/NC3) (23).
Histochemistry and morphometric analyses
Muscles were mounted in Tissue-Tek mounting medium (Sakura) and frozen in iso-pentane cooled with liquid nitrogen. 5 mm-thick sections were cut and stained with hematoxylin & eosin followed by imaging using a Leica Histology Microscope. Sections were stained with anti-fast and -slow myosin heavy chain antibodies (fMHC/sMHC; Sigma-Aldrich) and tiled images were captured with a Zeiss Cell Observer spinning disc confocal microscope. Muscle fiber area and fiber type distribution were determined using ImageJ 1.48V software.
Whole mount immunofluorescent stainings
Fresh muscle samples were cut into thin bundles and fixed with 2% PFA for 10 min at RT. After rinsing with PBS samples were permeabilized with PBS-1% Triton X-100 o/n at þ4 C. To block free PFA samples were neutralized with 100 mM glycine/PBS for 15 min at RT after which they were blocked with 2.5% FBS, 2.5% BSA/PBS-0.1% Triton X-100 o/n at þ4 C. Samples were incubated o/n or over two nights at þ4 C in blocking buffer with primary antibodies followed by washing with blocking buffer and incubation with Alexa Fluor-conjugated (Molecular Probes, Invitrogen) secondary antibodies in blocking buffer in combination with Alexa Fluor-conjugated a-Bungarotoxin (a-BTX; Biotium and Molecular Probes, Invitrogen) or Fasciculin II (Fasc II; Latoxan). For more information, see the Supplementary Material, Table S2 and S3. Immunostainings were imaged using an Olympus FV1000 scanning confocal microscope, a Zeiss Cell Observer spinning disc confocal microscope or a Zeiss LSM 780 laser scanning confocal microscope, and NMJ size and fragmentation were analyzed by ImageJ 1.48V software.
Ultrastructural analyses
1 Â 1 mm pieces of the diaphragm muscle at NMJ-rich areas were fixed with 1% glutaraldehyde, 4% PFA/0.1 M phosphate buffer, pH 7.3 o/n at þ4 C after which they were postfixed with 1% osmium tetroxide, dehydrated in acetone, and embedded in Epon LX112. Samples were cut in semi-thin sections and after further selecting NMJ-rich areas thin sections were prepared and analyzed with a Tecnai G2 Spirit 120 kV transmission electron microscope with Veleta and Quemesa CCD cameras and a Philips CM100 equipped with CCD camera.
Electrophysiological measurements ex vivo
Electrophysiological recordings were made from diaphragm muscles ex vivo at RT. Mice were euthanized and diaphragms were immediately dissected into 2-4 muscle strips with 4-12 synapses. Release of the readily releasable pool of the transmitter was induced by 500 mM sucrose. To prevent muscle contractions and preserve a physiologically high level of transmitter release in experiments with stimulation of the motor nerve, muscles were incubated with 2 mM m-conotoxin (SigmaAldrich) for 30 min before the experiments. EPPs were induced by the suprathreshold stimulation of the phrenic nerve. EPPs and MEPPs (recorded at the membrane potential $70-72 mV) digitized at 50 kHz were recorded using a low-noise custommade amplifier and acquired to the PC using the data acquisition board NI PCI6221 (National Instruments) and visualized with the WinEDR V3.0.4 software (Strathclyde University, Glasgow, Scotland, UK). Amplitudes of EPPs and MEPPs, and interevent intervals of MEPPs were analyzed off-line with the WinEDR V3.0.4 and ClampFit V10.2.0.14 (Molecular Devices) software.
Grid Hanging
Mice were placed on a wire-rack with 1 Â 1 cm grids, inverted slowly, placed on the height of 30 cm where after latency to fall was measured. 5 minutes was set as a maximum hanging time. DAP in saline (1 mg/kg) was injected intra peritoneally and the hanging time was evaluated 10 to 20 minutes later (35) . The same was repeated on the following day with a saline injection.
Binding Assays
Globular AChE dimer, tetramer, and asymmetric collagen-tailed forms were extracted and purified from Torpedo californica or Electrophorus electricus (36) (37) (38) (39) . All the samples were extracted by sedimentation in 5-20% sucrose gradients. Recombinant human collagen XIII or its pepsin-resistant collagenous domains (27) was coated onto the surface of a 96-well plate (MaxiSorb, NUNC). Diluted AChE samples were incubated on wells coated with either collagen XIII or control proteins and after washing bound AChE was evaluated by the Ellman's AChE activity assay using acetylthiocholine as a substrate (25) by measuring products at 405 nm using a Victor Multilabel Plate Reader (PerkinElmer).
Statistical Analyses
The data are presented as mean 6 SEM mouse-wise calculated, if not otherwise stated. Normality of the data was evaluated using the Kolmogorov-Smirnov test. The statistical significance of normally distributed data was calculated by the unpaired, twotailed t-test, and for non-parametric data, or if the sample number was too small for evaluating normality, the Mann-Whitney test was used. Statistical analyses were performed using the Prism (GraphPad Software, Inc.) and Origin graphic software (v.8.0, OriginLab Corp.). Statistically significant differences are indicated as *P < 0.05, **P < 0.01 and ***P < 0.001.
Supplementary Material
Supplementary Material is available at HMG online.
